1. | | Recruiting | Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer Conditions: stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum |
2. | | Recruiting | Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia Condition: Head and Neck Cancer |
3. | | Recruiting | Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation Condition: veno-occlusive disease |
4. | | Recruiting | Epirubicin and Thalidomide in Treating Patients With Liver Cancer Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ... |
5. | | Recruiting | Flavopiridol in Treating Patients With Metastatic or Unresectable Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Mesothelioma, Renal Cell Carcinoma (Kidney Cancer), Squamous Cell Carcinoma of the Head and Neck, Small Cell Lung Cancer, or Invasive Breast Cancer Conditions: Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; thorax and respiratory cancer |
6. | | Recruiting | Gemcitabine and Flavopiridol in Treating Patients With Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
7. | | Recruiting | Intrathecal and Systemic Chemotherapy Combined With Radiation Therapy in Treating Young Patients With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors Condition: childhood rhabdoid tumor of the central nervous system |
8. | | Recruiting | KRN5500 in Treating Patients With Solid Tumors Condition: unspecified adult solid tumor, protocol specific |
9. | | Recruiting | Letrozole in Preventing Breast Cancer in Postmenopausal Women Conditions: Breast Cancer; breast cancer in situ |
10. | | Recruiting | Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer Conditions: recurrent breast cancer; stage IV breast cancer |
11. | | Recruiting | Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer Conditions: acute leukemia; atypical chronic myeloid leukemia; Melanoma; myelodysplastic and myeloproliferative disease; Non-small cell lung cancer; ... |
12. | | Recruiting | ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer Conditions: lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer |
13. | | Recruiting | PKC412 in Patients with Acute Myeloid Leukemia and Patients with Myelodysplastic Syndrome with either Wild Type or Mutated FLT3 Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes |
14. | | Recruiting | Safety and Efficacy of Atiprimod for Patients with Refractory Multiple Myeloma Condition: Multiple Myeloma |
15. | | Recruiting | Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Conditions: Mixed Gliomas; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma |
16. | | Recruiting | Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma Conditions: adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas |
17. | | Recruiting | Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer |
18. | | Recruiting | Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer |
19. | | Recruiting | Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor Conditions: Brain Tumor; childhood brain tumor; childhood soft tissue sarcoma; gastrointestinal stromal tumor; Muscle Cancer |
20. | | Recruiting | Vaccine Therapy in Treating Patients With Metastatic Breast Cancer Conditions: stage IV breast cancer; Male Breast Cancer; recurrent breast cancer |
21. | | Recruiting | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma Conditions: Recurrent Melanoma; stage III melanoma; Stage IV Melanoma |